Author: Mary Kastens

New School of Medicine research, in mice, indicates that a natural sugar called trehalose blocks glucose from the liver and activates a gene that boosts insulin sensitivity, reducing the chance of developing diabetes.

A research team at the School of Medicine has found that laser treatment designed to destroy the deadly brain cancer glioblastoma can add an average of two months to a patient’s life, compared with chemotherapy. The increase is small but meaningful for people who have only months left to live.

Research led by the School of Medicine found that community outreach and education are critical for individuals navigating health insurance options available in the Affordable Care Act (ACA) marketplace. Such efforts at the state level may have contributed to a higher enrollment among Missourians in 2018.

Historic buildings that once housed St. Louis’ first Shriners Hospital for Children and the old Central Institute for the Deaf opened Aug. 1 as the newly renovated and named Core Apartment Residences on the Washington University Medical Campus.

People with depression who are treated with nerve stimulation experience significant improvements in quality of life, even when their depression symptoms don’t completely subside, according to results of a national study led by School of Medicine researchers.

School of Medicine researchers are trying a different approach to alleviate depression. Using CRISPR technology, the scientists have been able to target a different type of receptor in the brain that may be aided by natural mood-boosting substances.

A new School of Medicine study shows that children born with neurofibromatosis (NF1), a common genetic syndrome, are much more likely to have brain tumors than previously thought.

The School of Medicine has joined with Mallinckrodt Pharmaceuticals in a collaborative research partnership aimed at pursuing new therapies for patients with complex medical conditions, especially rare diseases that may have few or no treatment options. The global pharmaceutical company will fund up to $10 million over five years.

Researchers at Washington University School of Medicine are leading a national, multicenter study exploring whether testosterone plus exercise can restore physical abilities in elderly women who have broken a hip. The study is funded with a $15.6 million National Institutes of Health (NIH) grant.

Researchers from the School of Medicine and other institutions have sequenced the whole genomes of more than 100 metastatic prostate tumors, revealing new information about what drives the aggressive forms of this cancer.